Weekly News Round-up – 27/3/20
4 years ago
By Josh Neil
It’s that time again! We’ve got all the news you wanted this week, as long as you wanted to read about nothing except COVID-19, constantly. But to cheer things up, we’ve left out the story that we’re heading towards a worse financial impact than the 2008 crisis. Welcome back to:
The Round-up Coronavirus Special
(Part 2 of 30,000)
PHARMA GIANTS COLLABORATE ON COVID-19 TREATMENT – Several big pharma companies, including Novartis and J&J, are collaborating to develop COVID-19 vaccines. The 15 companies will share data and proprietary molecule libraries, following a recent conference call.
GILEAD ASKS FDA TO RESCIND ORPHAN DRUG STATUS OF REMDESIVIR AFTER CRITICISM – Gilead has requested that the FDA rescind the orphan drug status recently given to Remdesivir, a potential treatment for COVID-19. Gilead made the suggestion after public backlash that this could incentivise price-raises. Small-scale Chinese trials recently found the drug was efficacious in coronavirus patients. Demand for the drug is so high that last Saturday Gilead announced it will halt emergency access to it, due to “overwhelming demand”.
NICE UPDATE COVID-19 GUIDELINES – NICE has published the first of three guidelines on managing patients with and without COVID-19. These cover critical care, kidney dialysis and treatment of patients receiving systemic anticancer treatments. Among other things, the guidelines set out discussions with patients and families about risks and benefits of treatments, and making decisions on the basis of medical benefit.
In other news:
R&D
Sanofi and Translate Bio working together on novel COVID-19 mRNA vaccine
Clinical Trials
UK to begin clinical testing of COVID-19 next month
Manufacturing
That’s all for now. See you next week!
Joshua Neil, Editor
Proventa International
To ensure you remain up-to-date on the latest in clinical development, sign up for Proventa International’s online Clinical Operations, Supply Chain & Pharmacovigilance Strategy Meeting 2020.
Role of an Immunologist: Exploring the Responsibilities
In the intricate web of human health, the immune system stands as a vigilant guardian, tirelessly defending against potential threats. At the forefront of understanding, deciphering, and harnessing the immune system's power is the immunologist. This article delves into the...
2 months agoRole of an Immunologist: Exploring the Responsibilities
In the intricate web of human health, the immune system stands as a vigilant guardian, tirelessly defending against potential threats. At the forefront of understanding, deciphering, and harnessing the immune system's power is the immunologist. This article delves into the...
2 months ago
Improving Warehouse Efficiency: The Role of Technology and Best Practices
In the fast-paced world of supply chain management, warehouse efficiency plays a pivotal role in ensuring timely and accurate order fulfillment while minimizing costs. With the rising demands of e-commerce and globalization, businesses are continually seeking innovative ways to optimize...
2 months agoImproving Warehouse Efficiency: The Role of Technology and Best Practices
In the fast-paced world of supply chain management, warehouse efficiency plays a pivotal role in ensuring timely and accurate order fulfillment while minimizing costs. With the rising demands of e-commerce and globalization, businesses are continually seeking innovative ways to optimize...
2 months ago
How to Reduce the Cost of Clinical Trial Supply Chain While Maintaining Quality and Efficiency
Clinical trial supply chain is a critical component of drug development, ensuring that drugs are available for testing, regulatory approval, and distribution. However, managing this supply chain can be challenging, with factors such as cost, quality, and efficiency all coming...
7 months agoHow to Reduce the Cost of Clinical Trial Supply Chain While Maintaining Quality and Efficiency
Clinical trial supply chain is a critical component of drug development, ensuring that drugs are available for testing, regulatory approval, and distribution. However, managing this supply chain can be challenging, with factors such as cost, quality, and efficiency all coming...
7 months ago